Patient reported outcomes (PROS) in psoriasis patients
Marron, S.E. ; Cerro-Muñoz, P.A. ; Palma-Ruiz, A.M. ; Simal-Gil, E. (Universidad de Zaragoza) ; Garcia-Felipe, R. (Universidad de Zaragoza) ; Porta-Aznarez, N. (Universidad de Zaragoza) ; Martin-Marco, R. ; Baldellou-Lasierra, R. ; Gilaberte-Calzada, Y. (Universidad de Zaragoza) ; Alcalde-Herrero, V.M. ; Fuentelsaz del Barrio, M.V. ; Garcia-Latasa de Aranibar, F.J. (Universidad de Zaragoza) ; Alvarez-Salafranca, M. (Universidad de Zaragoza) ; Tomas-Aragones, L. (Universidad de Zaragoza)
Resumen: P20
Introduction: Psoriasis is a chronic skin disease with negative physical, mental and social manifestations. Method: We carried out a longitudinal and prospective study under routine clinical practice conditions. The objective of the study was to measure quality of life with the Short Form-36 Survey (SF-36) and correlate the results with clinical variables using the PASI and BSA in a group of 17 patients with moderate to severe psoriasis treated with Ustekinumab. Results: In the baseline evaluation we observed the following results: 35.3% reported physical malfunction, 64.7% debilitating pain, 82.3% poor health in general, 76.4% bad vitality, 88.2% social malfunction, 100% emotional malfunction and 82.3% poor mental health. At week 78 we observed the following results: 41.15% reported very good physical functioning, 76.1% no pain, 58.8% good general health, 58.8% very good vitality, 70%, 5% good social functioning, 70.5% good emotional functioning and 52.9% good mental health. Conclusion: We observed that the perception of patients with moderate-severe psoriasis regarding their health at the beginning of treatment with Ustekinumab was poor and that they experienced a significant improvement throughout the successive weeks of treatment.
Idioma: Inglés
Año: 2019
Publicado en: ACTA DERMATO-VENEREOLOGICA 99, 8 (2019), 752
ISSN: 0001-5555
Originalmente disponible en: Texto completo de la revista
Factor impacto JCR: 4.016 (2019)
Categ. JCR: DERMATOLOGY rank: 7 / 68 = 0.103 (2019) - Q1 - T1
Factor impacto SCIMAGO: 1.01 - Medicine (miscellaneous) (Q1) - Dermatology (Q1)
Tipo y forma: Congress (Published version)
Área (Departamento): Área Psicolog.Evolut.Educac (Dpto. Psicología y Sociología)
Área (Departamento): Área Dermatología (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2021-01-28-12:42:48)
Visitas y descargas
Introduction: Psoriasis is a chronic skin disease with negative physical, mental and social manifestations. Method: We carried out a longitudinal and prospective study under routine clinical practice conditions. The objective of the study was to measure quality of life with the Short Form-36 Survey (SF-36) and correlate the results with clinical variables using the PASI and BSA in a group of 17 patients with moderate to severe psoriasis treated with Ustekinumab. Results: In the baseline evaluation we observed the following results: 35.3% reported physical malfunction, 64.7% debilitating pain, 82.3% poor health in general, 76.4% bad vitality, 88.2% social malfunction, 100% emotional malfunction and 82.3% poor mental health. At week 78 we observed the following results: 41.15% reported very good physical functioning, 76.1% no pain, 58.8% good general health, 58.8% very good vitality, 70%, 5% good social functioning, 70.5% good emotional functioning and 52.9% good mental health. Conclusion: We observed that the perception of patients with moderate-severe psoriasis regarding their health at the beginning of treatment with Ustekinumab was poor and that they experienced a significant improvement throughout the successive weeks of treatment.
Idioma: Inglés
Año: 2019
Publicado en: ACTA DERMATO-VENEREOLOGICA 99, 8 (2019), 752
ISSN: 0001-5555
Originalmente disponible en: Texto completo de la revista
Factor impacto JCR: 4.016 (2019)
Categ. JCR: DERMATOLOGY rank: 7 / 68 = 0.103 (2019) - Q1 - T1
Factor impacto SCIMAGO: 1.01 - Medicine (miscellaneous) (Q1) - Dermatology (Q1)
Tipo y forma: Congress (Published version)
Área (Departamento): Área Psicolog.Evolut.Educac (Dpto. Psicología y Sociología)
Área (Departamento): Área Dermatología (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2021-01-28-12:42:48)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > psicologia_evolutiva_y_de_la_educacion
articulos > articulos-por-area > dermatologia
Notice créée le 2021-01-28, modifiée le 2021-01-28